Anthony Eisenberg
About Anthony D. Eisenberg
Anthony D. Eisenberg, 43, is an independent Class II director of Abpro Holdings, Inc. (ABP) serving since the November 2024 business combination; his current board term runs through 2026. He chairs the Audit, Compensation, and Nominating & Corporate Governance Committees and is designated by the board as an “audit committee financial expert.” He previously served as Chief Strategy Officer and a director at Abpro’s SPAC predecessor (ACAB), manages Tappan Street (a multi‑strategy family office), and holds an MBA (Georgetown McDonough), JD (University of Michigan), and BBA (University of Miami). He is classified as independent under Nasdaq rules.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Atlantic Coastal Acquisition Corp. II (ACAB) | Chief Strategy Officer and Director | CSO and director since Jan 2022; director through the Nov 2024 business combination | SPAC sponsor leadership and board role prior to de‑SPAC into Abpro |
| Atlantic Coastal Acquisition Corp. I (ACA I) | Chief Strategy Officer and Director | Feb 2021 – Oct 2023 | SPAC leadership/board experience |
| Christofferson Robb & Company | Investor (career start in principal investing) | Prior to 2013 | Early career in hedge fund investing |
| Office of U.S. Senator Debbie Stabenow; Patton Boggs; Marwood Group | Political/policy and research roles | Prior to principal investing | Public policy exposure and research background |
External Roles
| Organization | Role | Since/Through | Notes |
|---|---|---|---|
| Tappan Street (family office) | Manager | Since 2013 | ESG and private markets focus |
| Komma (mobility company) | Board of Advisors | Since Mar 2020 | Advisory role (non‑public) |
| Michigan Income Principal‑Protected Growth Fund | Board of Advisors | 2013 – 2019 | Impact investing fund tied to State of Michigan/US Treasury |
Board Governance
| Item | Disclosure |
|---|---|
| Director class/term | Class II; term expires at 2026 annual meeting |
| Independence | Independent; board majority independent (ex‑CEO Ian Chan and CEO Miles Suk are not independent) |
| Committee assignments | Audit; Compensation; Nominating & Corporate Governance |
| Committee chair roles | Chair of all three committees (Audit, Compensation, Nominating & Governance) |
| Audit committee financial expert | Board determined Eisenberg qualifies under Item 407(d)(5) Reg S‑K |
| Executive sessions | Independent directors hold executive sessions at least twice per year |
| 2024 board/committee meetings | Board: no meetings (directors appointed Nov 13, 2024). Audit Committee: met twice in 2024; Compensation and Nominating committees: did not meet in 2024 |
Fixed Compensation
| Element | Annual Amount | Notes |
|---|---|---|
| Board cash retainer | $40,000 | Paid quarterly in arrears; prorated if partial service |
| Audit Chair retainer | $15,000 | Additional to board retainer |
| Compensation Chair retainer | $10,000 | Additional to board retainer |
| Nominating & Gov. Chair retainer | $8,000 | Additional to board retainer |
| Committee member retainers | Audit $7,500; Compensation $5,000; Nominating $4,000 | Chair retainers apply for chairs; policy lists member retainers separately |
| Implied annual cash for Eisenberg (given roles) | $113,000 | Sum of board retainer + all three chair retainers based on current chair roles (40,000+15,000+10,000+8,000); policy‑based calculation |
Performance Compensation
| Grant Date | Instrument | Shares/Units | Vesting | Change‑of‑Control | Notes |
|---|---|---|---|---|---|
| July 2025 | Stock options | 60,600 | Cliff vest on first anniversary of grant | Accelerates in full | Initial “onboarding” award per director policy; each non‑employee director, including Eisenberg, received 60,600 options in July 2025 |
| Annual meeting each year | Stock options | 30,300 | Cliff vest on first anniversary of grant | Accelerates in full | Ongoing annual director grant policy |
No performance metrics are tied to director equity awards; awards are time‑based options per the disclosed policy.
Other Directorships & Interlocks
| Item | Disclosure |
|---|---|
| Current other public company boards | 0 (as of record date table) |
| Compensation committee interlocks | None; no officer of ABP sits on a board/comp committee with ABP executives cross‑serving |
Expertise & Qualifications
- ESG and private markets investing; policy/government affairs; capital markets strategy (SPAC executive experience).
- Board‑designated audit committee financial expert with finance education/experience; can read and understand financial statements.
Equity Ownership
| Metric | Amount |
|---|---|
| Beneficial ownership (common shares) | Not listed as a beneficial owner; footnote notes 60,600 options not exercisable within 60 days of Sept 2, 2025 |
| Options/awards (status) | 60,600 options granted July 2025; not exercisable within 60 days of Sept 2, 2025 (i.e., unvested at that date) |
| Hedging/derivatives policy | Directors prohibited from hedging (collars, forwards) and trading in derivatives on company securities |
| Pledging policy | Pledging prohibited except in extraordinary circumstances with pre‑clearance; no pledging by Eisenberg disclosed |
| Ownership guidelines | Proxy states no formal stock ownership guidelines for executive officers and does not disclose any director‑specific ownership guidelines |
Governance Assessment
-
Strengths
- Independence and concentration of governance responsibilities: Eisenberg is independent, chairs the three key committees, and is designated the audit committee financial expert—supporting board oversight of financial reporting, pay, and nominations.
- Anti‑hedging/pledging controls and clawback: robust insider trading policy (hedging/pledging restrictions) and an exchange‑compliant clawback policy adopted (with restatement disclosure and no recovery triggered).
- No interlocks and no other public board commitments (limits overboarding risk).
-
Watch items / potential red flags
- Committee chair concentration: One director chairing Audit, Compensation, and Nominating centralizes oversight; boards sometimes diversify chairs to mitigate key‑person risk. This is mitigated by full committee independence and reporting to the board.
- Alignment/“skin in the game”: As of the Sept 2, 2025 record date, Eisenberg was not reported as a beneficial common shareholder; his 60,600 director options were unvested/not exercisable within 60 days, implying limited near‑term ownership alignment versus cash retainers plus unvested options.
- SPAC affiliation optics: Eisenberg’s prior executive/director role at ACAB (the SPAC that merged with Abpro) can raise perceived conflicts; however, the proxy outlines related‑party review procedures and independence determinations, and discloses extensive SPAC‑related transactions and safeguards.
-
Company context raising governance scrutiny
- Nasdaq minimum bid deficiency prompted a reverse split proposal; stockholders ultimately approved a 1‑for‑30 reverse split at the October 10, 2025 annual meeting (original proxy noted 1‑for‑10; final approval was 1‑for‑30). Boards often face heightened investor focus on capital stewardship and governance during such periods.
No director‑specific related‑party transactions, loans, or pledging by Eisenberg were disclosed in the proxy; compensation committee interlocks are explicitly stated as none.